Industry Standard Research
Toggle navigation
Register
Log In
Search for:
Reports
Full Report List
Manufacturing Reports
Service Provider Quality Benchmarking Reports
Trends & Technology Reports
Clinical Trial Recruitment & Retention Reports
Commercialization Reports
Department Models & Structures Reports
Biosimilars & Biologics Reports
Library Access Subscription
Targeted Distribution
Custom Research
Free Resources
Core Industry Metrics
Infographics
White Papers
Industry Statistics
About
ISR Health Panel
Our Customers
Community Involvement
Media Center
Careers
Contact Us
Industry Statistics
Free Resource
April ’19: Are Outsourcers Interested In Changing Their CRO Mix?
March ’19: What goes into a CRA Salary?
February ’19: mHealth in Clinical Trials—Why and How?
January ’19: Clinical Research M&A—A Slower Year
December ’18: A Look at 2018’s CDMO Expansions
November ’18: The Interconnected World of Blockbuster Oncology Drugs
October ’18: The Top 5 Selection Drivers for Phase IV Services
September ’18: Department Influence On CMO Selection
August ’18: Choosing a development stage eCOA/ePRO provider
July ’18: What are the largest slices of the CRO Market?
June ’18: Is the U.S. Biosimilar Industry Falling Behind?
May ’18: Trial Data Collection—Paper vs. Electronic
April ’18: 10 Years of CRO Performance
March ’18: The Evolution of IRT (or whatever you call it)
February ’18: A Year’s Worth of Drug Approvals
January ’18: What Drives CRO Preferred Provider Selection?
ISR CUSTOMERS
